aspirin has been researched along with n-methylaspartate in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.69) | 18.7374 |
1990's | 4 (30.77) | 18.2507 |
2000's | 7 (53.85) | 29.6817 |
2010's | 1 (7.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lehmann, A | 1 |
Grilli, M; Memo, M; Pizzi, M; Spano, P | 1 |
Alberti, L; De Montis, MG; Franconi, F; Miceli, M; Seghieri, G; Tagliamonte, A | 1 |
Choi, EJ; Gwag, BJ; Han, PL; Kim, H; Kim, YU; Ko, HW; Park, KY | 1 |
Hartmann, A; Mohr, JP | 1 |
Chang, SY; Chung, JM; Gwag, BJ; Han, PL; Joo, CK; Kang, K; Kim, EY; Moon, HS; Ryu, BR; Yoon, SH | 1 |
Gwag, BJ; Kim, D; Kim, SD; Lee, YA; Moon, HS; Nam, SI; Yoon, SH | 1 |
Chen, S; Lin, X; Peng, BG | 1 |
Crisanti, P; Leon, A; Lim, DM; Omri, B | 1 |
Crisanti, P; Jeanny, JC; Jonet, L; Laplace, O; Lecain, E; Omri, B | 1 |
Ahn, YM; Byun, HY; Cho, JY; Cho, SI; Chung, JM; Gwag, BJ; Im, DS; Kim, KW; Ko, SY; Kwon, HJ; Lee, HU; Lee, JY; Lee, MJ; Lee, YA; Lim, HR; Moon, HS; Noh, JH; Park, SM; Son, SJ; Won, SJ; Yoon, SH; Yun, BS | 1 |
Han, PL; Jeong, JY; Kim, HJ; Kim, SW; Lee, JK; Seo, JS; Yoon, SH | 1 |
13 other study(ies) available for aspirin and n-methylaspartate
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Pharmacological protection against the toxicity of N-methyl-D-aspartate in immature rat cerebellar slices.
Topics: Animals; Aspartic Acid; Aspirin; Calcium Channel Blockers; Cerebellum; Female; In Vitro Techniques; Indomethacin; Kynurenic Acid; Leupeptins; Male; N-Methylaspartate; Rats; Rats, Inbred Strains; Taurine | 1987 |
Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation.
Topics: Animals; Aspirin; Calcium; Cell Survival; Cells, Cultured; Cerebellum; Dentate Gyrus; Glutamic Acid; Hippocampus; In Vitro Techniques; N-Methylaspartate; Neurons; Neuroprotective Agents; NF-kappa B; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Sodium Salicylate; Transcription Factor AP-1; Up-Regulation | 1996 |
Further insights into the anti-aggregating activity of NMDA in human platelets.
Topics: Aspirin; Blood Platelets; Calcium; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; In Vitro Techniques; Indomethacin; N-Methylaspartate; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Aggregation Inhibitors; Thromboxane B2 | 1998 |
Ca2+-mediated activation of c-Jun N-terminal kinase and nuclear factor kappa B by NMDA in cortical cell cultures.
Topics: Animals; Aspirin; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Cerebral Cortex; Enzyme Activation; Fetus; JNK Mitogen-Activated Protein Kinases; Mice; Mitogen-Activated Protein Kinases; N-Methylaspartate; NF-kappa B | 1998 |
Treatment of acute ischemic stroke: where are we?
Topics: Animals; Aspirin; Brain Damage, Chronic; Brain Ischemia; Calcium Channel Blockers; Cerebral Hemorrhage; Cerebrovascular Circulation; Clinical Trials as Topic; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; N-Methylaspartate; Neuroprotective Agents; Platelet Aggregation Inhibitors; Reperfusion Injury; Rodentia; Thrombolytic Therapy; Warfarin | 1999 |
Attenuation of Zn2+ neurotoxicity by aspirin: role of N-type Ca2+ channel and the carboxyl acid group.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Aspirin; Benzoates; Calcium; Calcium Channels, N-Type; Cerebral Cortex; Chromans; Excitatory Amino Acid Agonists; Ion Channel Gating; Ion Transport; Membrane Potentials; Mice; N-Methylaspartate; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; omega-Conotoxin GVIA; omega-Conotoxins; Staurosporine; Structure-Activity Relationship; Zinc | 2001 |
Structural requirements for the neuroprotective effects of aspirin analogues against N-methyl-D-aspartate and zinc ion neurotoxicity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carboxylic Acids; Cerebral Cortex; Excitatory Amino Acid Agonists; Ions; Mice; Mice, Inbred ICR; N-Methylaspartate; Neuroprotective Agents; Zinc | 2002 |
Aspirin selectively augmented N-methyl-D-aspartate types of glutamate responses in cultured spiral ganglion neurons of mice.
Topics: Animals; Aspirin; Cells, Cultured; Dose-Response Relationship, Drug; Drug Combinations; Mice; N-Methylaspartate; Neurons, Afferent; Potassium Channels; Potassium Channels, Voltage-Gated; Receptors, Glutamate; Spiral Ganglion | 2003 |
Aspirin prevention of NMDA-induced neuronal death by direct protein kinase Czeta inhibition.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Caspase 3; Caspases; Cell Nucleus; Excitatory Amino Acid Agonists; N-Methylaspartate; Neurons; Neuroprotective Agents; PC12 Cells; Protein Kinase C; Rats | 2005 |
The role of PKCzeta in NMDA-induced retinal ganglion cell death: prevention by aspirin.
Topics: Animals; Apoptosis; Aspirin; Male; N-Methylaspartate; Protein Kinase C; Rats; Rats, Wistar; Retinal Ganglion Cells | 2006 |
Marked prevention of ischemic brain injury by Neu2000, an NMDA antagonist and antioxidant derived from aspirin and sulfasalazine.
Topics: Animals; Antioxidants; Aspirin; Benzoates; Brain Ischemia; Cells, Cultured; Excitatory Amino Acid Antagonists; Fluorobenzenes; Infarction, Middle Cerebral Artery; meta-Aminobenzoates; Mice; N-Methylaspartate; Oxidative Stress; Receptors, N-Methyl-D-Aspartate; Salicylates; Sulfasalazine | 2007 |
Combination treatment with ethyl pyruvate and aspirin enhances neuroprotection in the postischemic brain.
Topics: Animals; Aspirin; Astringents; Astrocytes; Brain Infarction; Cells, Cultured; Cerebral Cortex; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Embryo, Mammalian; Excitatory Amino Acid Agonists; Gene Expression Regulation; Glucose; Hypoxia; Infarction, Middle Cerebral Artery; Male; N-Methylaspartate; Neurons; Neuroprotective Agents; NF-kappa B; Polysaccharides; Pyruvates; Rats; Rats, Sprague-Dawley; Rotarod Performance Test; Severity of Illness Index; Time Factors; Zinc Sulfate | 2010 |